Please register the webinar from the following link.
This year, with the introduction of ChatGPT, AI and generative AI have gained significant attention both domestically and internationally, across industries. The pharmaceutical industry has shown interest in and utilized AI-driven drug discovery, and efforts to utilize AI for property prediction have been established. However, while the environment surrounding AI is rapidly changing, many companies may still be in the early stage of considering molecular design.
To address this, Elix, an AI drug discovery company in Japan, will be hosting an introductory webinar on AI drug discovery, specifically focusing on molecular design, their fundamentals, and trends.
Introduction to the Webinar:
Takahiro Inoue, a research engineer at Elix, will provide an explanation of the fundamentals and trends in molecular design. Takahiro obtained his Ph.D. from the Graduate School of Engineering at the University of Tokyo, specializing in chemical systems engineering. Since joining Elix, he has conducted numerous lectures for pharmaceutical companies. He has also coauthored two books on materials informatics while still in academia. With the goal of enhancing participants’ understanding of molecular design, Takahiro will deliver a detailed presentation.
– Overview of this seminar
Seminar Title: “Introduction to AI Drug Discovery Webinar – Fundamentals and Trends in Molecular Design”
Date & Time: Thursday, June 8, 2023, 14:00-15:00 (Online via Zoom, Free of charge)
(1) Introduction (10 minutes)
(2) Presentation by Takahiro Inoue (45 minutes)
(3) Q&A session (5 minutes)